News

Print Share

Sight recovery in retinitis pigmentosa?

Researchers from the Institut de la Vision have contributed to a study with scientists from the Friedrich Miescher Institute for Biomedical Research (FMI), Basel, Switzerland, to restore vision in retinitis pigmentosa.

This novel strategy relies on introducing a photosensitive archaebacterial protein (halorhodopsin) into the remaining but non-functional cone photoreceptors. The concept was first demonstrated on a blind mouse and subsequently confirmed in light-insensitive human retinas in vitro. The types of patients who could benefit from this therapy have also been determined.

These findings could lead in the future to the development of a new therapeutic approach for retinitis pigmentosa that is, at present, an incurable condition.

These breaking results were published in the journal Science (source).

For more information, see the material provided by Inserm, click here.

Created Tuesday, 29 June 2010 Last modified Tuesday, 29 June 2010

© 2010 Fondation Voir et Entendre. Tous droits réservés. Une réalisation Sud Edito et h2studio